 Persistence Theiler virus infection promotion central nervous system remyelination Chronic infection SJL/J mice Daniel strain Theiler virus primary demyelination viral persistence minimal central nervous system CNS -type remyelination contrast treatment virus-infected mice sera immunoglobulin IgG mice homogenized spinal cord SCH incomplete Freund adjuvant promotes CNS remyelination levels infectious virus virus antigen virus-specific antibody treatments CNS remyelination able infection Levels virus-specific antibody mice SCH/IgG control treatment groups extent remyelination number virus antigen-positive cells spinal cord mice SCH/IgG phosphate saline PBS /IgG slight negative correlation extent remyelination regression analysis Titers infectious virus months infection different treatment groups treatment mice SCH/IgG number virus antigen-positive cells enhanced levels virus-specific antibody CNS remyelination presence infectious virus